Assessment of cyclooxygenase inhibitors using in vitro assay systems

Methods in Cell Science

Volumn 19, Issue 1, 1997, Pages 25-31

  Jang, Mei Shiang ^a   Pezzuto, John M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Assay; Co oxidation; Cyclooxygenase; Inhibitor; Oxygen consumption; Peroxidase

Indexed keywords

ACETYLSALICYLIC ACID; AFZELECHIN; ANTINEOPLASTIC AGENT; CATECHIN; CURCUMIN; FISETIN; GALLIC ACID; GLUCOSE DERIVATIVE; INDOMETACIN; MECLOFENAMATE SODIUM; MORIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NORDIHYDROGUAIARETIC ACID; OXYGEN; PEROXIDASE; PIROXICAM; PLANT EXTRACT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; QUERCETIN; RESVERATROL; SCAVENGER; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME INHIBITOR INTERACTION; MALE; NONHUMAN; OXIDATION; OXYGEN CONSUMPTION;

EID: 0030966126     PISSN: 13815741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009742504152     Document Type: Article

References (11)

1. Boynton CS, Dick CF, Mayor GH (1988). NSAIDs: An overview. J Clin Pharmacol 28: 512-517.
2. Greenberg ER, Baron JA (1993). Prospects for preventing colorectal cancer death. J Natl Cancer Inst 85: 1182-1184.
3. Kune GA, Kune S, Watson LF (1988). Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48: 4399-4404.
4. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S (1991). A hypothesis: Nonsteroidal antiinflammatory drugs reduce the incidence of large bowel cancer. J Natl Cancer Inst 83: 355-358.
5. Van der Ouderaa FJG, Buytenhek M (1982). Purification of PGH synthase from sheep vesicular glands. Meth Enzymol 86: 60-68.
6. Kulmacz RJ, Lands EM (1987). Cyclooxygenase: measurement, purification and properties. In: Benedetto C, McDonald-Gibson RG, Nigam S, Slater TF (eds), Prostaglandins and related substances: A practical approach. Oxford: IRL Press, Chap 12, pp 209-222.
7. Sano H, Hla T, Maier JAM, et al. (1992). In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 89: 97-108.
8. Kujubu DA, Herschman HR (1992). Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem 267: 7991-7994.
9. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S (1994). NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47: 55-59.
10. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC, Seibert K (1995). Expression and selective inhibition of the constitutive and inducible forms of human cyclooxygenase. Biochem J 305: 479-484.
11. Jang M, Cai L, Udeani GO, Slowing K, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.